论文部分内容阅读
在治疗小儿感染性休克的综合措施中,血管活性药物的应用是取得疗效的重要因素之一。但血管活性药物的应用,至今尚无规律可寻。近年来去甲肾上腺素(以下简称去甲肾)在治疗感染性休克中,被认为不宜应用或禁用。我们认为在某些危重情况时,使用此药尚有一定的实用价值。现将我科于1978年1～7月应用去甲肾治愈4例重症感染性休克病儿的情况介绍如下。临床资料 4例中3例为金黄色葡萄球菌感染,1例为中毒型痢疾。4例均作过心电图检查,可见有S-T及T段改变,诊断为心肌损害(表1)。一、应用去甲肾前的治疗: 在扩容、纠酸、强心等方面,4例病儿在治疗4～16小时内,分别补充液量1,409～2,400毫升/平方
In the comprehensive treatment of septic shock in children, the application of vasoactive drugs is one of the important factors to obtain curative effect. However, the application of vasoactive drugs, so far no law to find. In recent years, norepinephrine (hereinafter referred to as dementia) in the treatment of septic shock, is considered inappropriate or disabled. We think there is some practical value in using this medicine in certain critical situations. Now our department in January 1978 application of norethrenal treatment of 4 cases of severe septic shock in children are described below. Clinical data of 4 cases, 3 cases of Staphylococcus aureus infection, 1 case of poisoning dysentery. 4 cases were made by electrocardiogram examination, there are S-T and T segment changes, the diagnosis of myocardial damage (Table 1). First, the application of norethrenal treatment: in the expansion, correction of acid, cardiac and so on, 4 cases of sick children in the treatment of 4 to 16 hours, were added to the fluid volume 1,409 ~ 2,400 ml / square